- Home
- BCBP vs IKT Comparison
BCBP vs IKT Comparison
Compare BCBP & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- IKT
- Stock Information
- Founded
- BCBP 2000
- IKT 2008
- Country
- BCBP United States
- IKT United States
- Employees
- BCBP N/A
- IKT N/A
- Industry
- BCBP Savings Institutions
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- IKT Health Care
- Exchange
- BCBP Nasdaq
- IKT Nasdaq
- Market Cap
- BCBP 143.5M
- IKT 140.5M
- IPO Year
- BCBP N/A
- IKT 2020
- Fundamental
- Price
- BCBP $8.67
- IKT $1.84
- Analyst Decision
- BCBP Hold
- IKT Buy
- Analyst Count
- BCBP 2
- IKT 2
- Target Price
- BCBP $11.75
- IKT $8.00
- AVG Volume (30 Days)
- BCBP 96.8K
- IKT 521.3K
- Earning Date
- BCBP 07-29-2025
- IKT 08-13-2025
- Dividend Yield
- BCBP 7.37%
- IKT N/A
- EPS Growth
- BCBP N/A
- IKT N/A
- EPS
- BCBP 0.15
- IKT N/A
- Revenue
- BCBP $63,178,000.00
- IKT N/A
- Revenue This Year
- BCBP $22.28
- IKT N/A
- Revenue Next Year
- BCBP $10.55
- IKT N/A
- P/E Ratio
- BCBP $57.98
- IKT N/A
- Revenue Growth
- BCBP N/A
- IKT N/A
- 52 Week Low
- BCBP $7.54
- IKT $1.12
- 52 Week High
- BCBP $14.04
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- BCBP 53.31
- IKT 47.64
- Support Level
- BCBP $8.50
- IKT $1.76
- Resistance Level
- BCBP $8.86
- IKT $1.94
- Average True Range (ATR)
- BCBP 0.25
- IKT 0.15
- MACD
- BCBP -0.03
- IKT 0.00
- Stochastic Oscillator
- BCBP 38.27
- IKT 50.98
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.